Grant ID PP160097
Awarded On August 17, 2016
Title School-Based Human Papillomavirus Vaccination Program in the Lower Rio Grande Valley
Program Prevention
Award Mechanism Evidence-Based Prevention Programs and Services
Institution/Organization The University of Texas Medical Branch at Galveston
Principal Investigator/Program Director Ana Rodriguez
Cancer Sites Cervix Uteri
Contracted Amount $747,727
Lay Summary

The HPV vaccine reduces the morbidity and mortality of HPV-related diseases, including anogenital warts and cervical, oropharyngeal, vulvar, vaginal, penile, and anal cancer.[1-9] Guidelines recommend HPV vaccination for girls and boys aged 11–12, with catch-up doses for ages 13–26.[7,9]

We will use the 9-valent HPV vaccine, which covers 5 additional HPV cancer-causing types and is estimated to prevent 15% more cervical cancer than the quadrivalent vaccine. The 3-injection HPV vaccine series has to be given in early adolescence to maximize effectiveness. It provides the greatest benefit to adolescents before they become sexually active.[30] The Healthy People 2020 goal is to vaccinate ...

Read More